Genelux Corp. (GNLX)
2.56
+0.14
(+5.79%)
USD |
NASDAQ |
Apr 01, 16:00
2.55
-0.01
(-0.39%)
After-Hours: 20:00
Genelux EPS Diluted (Quarterly) : -0.2452 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 0.1493 |
| Arcutis Biotherapeutics, Inc. | 0.1282 |
| MBX Biosciences, Inc. | -0.4917 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.247M |
| Revenue (Quarterly) | 0.008M |
| Total Expenses (Quarterly) | 9.255M |
| Enterprise Value | 101.79M |
| Gross Profit Margin (Quarterly) | -1.75K% |
| Profit Margin (Quarterly) | -115.6K% |
| Earnings Yield | -32.10% |
| Normalized Earnings Yield | -32.10 |